Focus: NIH Eye Inst Grants

Filters close
Newswise: New Color-Coded Test Quickly Reveals If Medical Nanoparticles Deliver Their Payload
Released: 5-Jan-2022 2:00 PM EST
New Color-Coded Test Quickly Reveals If Medical Nanoparticles Deliver Their Payload
Johns Hopkins Medicine

Johns Hopkins Medicine researchers have developed a color-coded test that quickly signals whether newly developed nanoparticles — ultra small compartments designed to ferry medicines, vaccines and other therapies — deliver their cargo into target cells. The new testing tool, engineered specifically to test nanoparticles, could advance the search for next-generation biological medicines.

Newswise: Grants fund drug development for devastating tropical diseases
Released: 22-Dec-2021 12:05 PM EST
Grants fund drug development for devastating tropical diseases
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis have received two grants from the National Institutes of Health (NIH) totaling more than $5.5 million to develop new treatments for two types of devastating parasitic infections common in sub-Saharan Africa and Central and South America: river blindness and intestinal worm infections.

Newswise:Video Embedded nih-study-traces-molecular-link-from-gene-to-late-onset-retinal-degeneration
VIDEO
7-Dec-2021 12:15 PM EST
NIH study traces molecular link from gene to late-onset retinal degeneration
NIH, National Eye Institute (NEI)

Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease. Researchers from the National Eye Institute (NEI), part of the National Institutes of Health generated a “disease-in-a-dish” model to study the disease. The findings are published in Communications Biology.

Newswise:Video Embedded audacious-projects-develop-imaging-technology-to-aid-eye-tissue-regeneration2
VIDEO
Released: 22-Apr-2021 2:15 PM EDT
Audacious projects develop imaging technology to aid eye tissue regeneration
NIH, National Eye Institute (NEI)

As regenerative therapies for blinding diseases move closer to clinical trials, the National Eye Institute’s functional imaging consortium, a part of the NEI Audacious Goals Initiative (AGI), is pioneering noninvasive technologies to monitor the function of the retina’s light-sensing neurons and their connections to the brain.

Released: 9-Feb-2021 12:35 PM EST
UIC researcher awarded $10.15M to develop antibody-based dry eye treatment
University of Illinois Chicago

Researchers at the University of Illinois Chicago have been awarded a five-year, $10.15 million grant to develop a broad-spectrum immunomodulatory eye drop.

Newswise: Study suggests sugary diet endangers waste-eating protein crucial to cellular repair
Released: 15-Dec-2020 9:20 AM EST
Study suggests sugary diet endangers waste-eating protein crucial to cellular repair
Tufts University

A high-sugar diet creates a ‘double jeopardy’ impact for a protein crucial to cellular housekeeping, a new study suggests. The protein offsets cell damage from sugar, but too much sugar renders it ineffective. The results may offer insight for reducing age-related degenerative disease.

1-Dec-2020 5:15 PM EST
Scientists Reverse Age-Related Vision Loss, Eye Damage From Glaucoma in Mice
Massachusetts Eye and Ear

Proof-of-concept study represents first successful attempt to reverse the aging clock in animals through epigenetic reprogramming.

Newswise: QTSensor2-1024x729.jpg
Released: 16-Nov-2020 4:55 PM EST
Quantum Tunneling Pushes the Limits of Self-Powered Sensors
Washington University in St. Louis

Shantanu Chakrabartty’s laboratory has been working to create sensors that can run on the least amount of energy. His lab has been so successful at building smaller and more efficient sensors, that they’ve run into a roadblock in the form of a fundamental law of physics.Sometimes, however, when you hit what appears to be an impenetrable roadblock, you just have to turn to quantum physics and tunnel through it.

Newswise: FAU Researchers Receive $1.3 Million NIH Grant for Stem Cell Research
Released: 14-Oct-2020 8:30 AM EDT
FAU Researchers Receive $1.3 Million NIH Grant for Stem Cell Research
Florida Atlantic University

The NIH grant will enable FAU scientists to identify the gene regulation pathways activated to program immature stem-like cells of the eye lens to attain their mature form and transparent function. The research team plans to explore the genetic and cellular mechanisms controlling developmental DNA conformational changes and will identify the transcription factors needed for eye lens formation.

Newswise:Video Embedded world-s-first-pathoconnectome-could-point-toward-new-treatments-for-neurodegenerative-diseases
VIDEO
Released: 29-Sep-2020 4:50 PM EDT
World’s First ‘Pathoconnectome’ Could Point Toward New Treatments for Neurodegenerative Diseases
University of Utah Health

Scientists from the John A. Moran Eye Center at the University of Utah have achieved another first in the field of connectomics, which studies the synaptic connections between neurons. The National Institutes of Health (NIH)-funded lab has produced the first pathoconnectome, showing how eye disease alters retinal circuitry.

Newswise:Video Embedded mass-eye-and-ear-doctors-collaborate-with-dana-farber-to-rebuild-damaged-corneas-using-patients-own-stem-cells-for-first-time-in-united-states
VIDEO
27-Aug-2020 1:25 PM EDT
Mass Eye and Ear Doctors Collaborate with Dana-Farber to Rebuild Damaged Corneas Using Patients’ Own Stem Cells for First Time in United States
Massachusetts Eye and Ear

Surgeons at Mass Eye and Ear have replaced the ocular surface of four patients who each experienced chemical burns to one eye by using their own stem cells taken from the other healthy eye, in a technique known as “cultivated autologous limbal epithelial cell transplantation” (CALEC). These four cases, all part of an ongoing clinical trial supported by the National Eye Institute of the NIH, represent the first procedures of their kind to occur in the United States.

Newswise:Video Embedded multifocal-contact-lenses-slow-myopia-progression-in-children
VIDEO
6-Aug-2020 1:55 PM EDT
Multifocal contact lenses slow myopia progression in children
NIH, National Eye Institute (NEI)

Children wearing multifocal contact lenses had slower progression of their myopia, according to results from a clinical trial funded by the National Eye Institute, part of the National Institutes of Health. The findings support an option for controlling the condition, also called nearsightedness, which increases the risk of cataracts, glaucoma and retinal detachment later in life. Investigators of the Bifocal Lenses In Nearsighted Kids (BLINK) Study published the results August 11 in the Journal of the American Medical Association.

Newswise: Vision loss in children whose eyesight may be 20/20 requires new diagnostic and teaching strategies
Released: 15-Jul-2020 11:20 AM EDT
Vision loss in children whose eyesight may be 20/20 requires new diagnostic and teaching strategies
NIH, National Eye Institute (NEI)

Cerebral (cortical) visual impairment (CVI) is a condition that interferes with the ability of the brain to process information from the eyes, and it has become a leading cause of visual impairment in the U.S.

Newswise: Exercise can slow or prevent vision loss, study finds
Released: 1-Jul-2020 9:45 AM EDT
Exercise can slow or prevent vision loss, study finds
University of Virginia Health System

Exercise can slow or prevent the development of macular degeneration and may benefit other common causes of vision loss, such as glaucoma and diabetic retinopathy, new research suggests.

Newswise: Very low-dose Avastin effective for preventing blindness in preterm infants
21-Apr-2020 12:05 PM EDT
Very low-dose Avastin effective for preventing blindness in preterm infants
NIH, National Eye Institute (NEI)

Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently. Results from the dose-finding study were published April 23 in JAMA Ophthalmology. The study was conducted by the Pediatric Eye Disease Investigator Group (PEDIG) and supported by the National Eye Institute (NEI), part of the National Institutes of Health.

Newswise: ‘Primitive’ Stem Cells Shown to Regenerate Blood Vessels in The Eye
Released: 9-Mar-2020 9:00 AM EDT
‘Primitive’ Stem Cells Shown to Regenerate Blood Vessels in The Eye
Johns Hopkins Medicine

Johns Hopkins Medicine scientists say they have successfully turned back the biological hands of time, coaxing adult human cells in the laboratory to revert to a primitive state, and unlocking their potential to replace and repair damage to blood vessels in the retina caused by diabetes. The findings from this experimental study, they say, advance regenerative medicine techniques aimed at reversing the course of diabetic retinopathy and other blinding eye diseases.

Newswise: Potential Way to Halt Blinding Macular Degeneration Identified
Released: 22-Jan-2020 10:25 AM EST
Potential Way to Halt Blinding Macular Degeneration Identified
University of Virginia Health System

It would be the first treatment for "dry" age-related macular degeneration and could significantly improve treatment for wet AMD.

Newswise: Helper Protein Worsens Diabetic Eye Disease
Released: 27-Nov-2019 8:00 AM EST
Helper Protein Worsens Diabetic Eye Disease
Johns Hopkins Medicine

In a recent study using mice, lab-grown human retinal cells and patient samples, Johns Hopkins Medicine scientists say they found evidence of a new pathway that may contribute to degeneration of the light sensitive tissue at the back of the eye. The findings, they conclude, bring scientists a step closer to developing new drugs for a central vision-destroying complication of diabetes that affects an estimated 750,000 Americans.

Newswise: Finding A Cell’s True Identity
Released: 28-May-2019 10:00 AM EDT
Finding A Cell’s True Identity
Johns Hopkins Medicine

Scientists have long sorted cells into different varieties based on their appearance under a microscope or, for differences that are more visually subtle, based on the behavior of a handful of genes. But in a bid to reveal even more distinctive differences and similarities, researchers from the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins Institute for Genetic Medicine and the Johns Hopkins Department of Neuroscience developed two new artificial intelligence methods that decipher complex gene activity controlling cell fate decisions in retina development and relate this gene activity to what occurs in other tissues and across different species.

Newswise: Research Suggests Revision to Common View on How Retinal Cells in Mammals Process Light
Released: 16-May-2019 9:00 AM EDT
Research Suggests Revision to Common View on How Retinal Cells in Mammals Process Light
Johns Hopkins Medicine

Johns Hopkins Medicine scientists say that new experiments with mouse eye tissues strongly suggest that a longstanding “textbook concept” about the way a mammal’s retina processes light needs a rewrite.

Newswise: Experimental Drug Delivers One-Two Punch to Vision Loss
Released: 10-Apr-2019 10:00 AM EDT
Experimental Drug Delivers One-Two Punch to Vision Loss
Johns Hopkins Medicine

In studies with lab-grown human cells and in mice, Johns Hopkins Medicine researchers have found that an experimental drug may be twice as good at fighting vision loss as previously thought.

Newswise: Enzyme Helps Build Motor That Drives Neuron Death
2-Aug-2018 12:00 PM EDT
Enzyme Helps Build Motor That Drives Neuron Death
Vanderbilt University

The process, discovered in the axons of neurons, is implicated in Alzheimer’s, amyotrophic lateral sclerosis, traumatic brain injury and other diseases or injuries to the nervous system.

Newswise:Video Embedded a-sprinkle-of-platinum-nanoparticles-onto-graphene-makes-brain-probes-more-sensitive
VIDEO
Released: 14-Jun-2018 2:05 PM EDT
A sprinkle of platinum nanoparticles onto graphene makes brain probes more sensitive
University of California San Diego

Graphene electrodes could enable higher quality brain imaging thanks to new research by a team of engineers and neuroscientists at UC San Diego. The researchers developed a technique, using platinum nanoparticles, to lower the impedance of graphene electrodes by 100 times while keeping them transparent. In tests on transgenic mice, the electrodes were able to record and image neuronal activity (calcium ion spikes) at of large groups of neurons and individual brain cells.

Newswise: Low Vision Research Shifts Into Overdrive
Released: 22-Feb-2018 8:00 AM EST
Low Vision Research Shifts Into Overdrive
NIH, National Eye Institute (NEI)

Tim Goetz drives about 200,000 miles each year. Remarkably, Goetz is legally blind. Research funded by the National Eye Institute (NEI) is helping Goetz and others like him get or stay behind the wheel while keeping roads safe for everyone.

Newswise: NEI-Funded Research Suggests Repetitive Strain From Eye Movement May Play a Role in Glaucoma
Released: 4-Jan-2018 10:05 AM EST
NEI-Funded Research Suggests Repetitive Strain From Eye Movement May Play a Role in Glaucoma
NIH, National Eye Institute (NEI)

Common, unavoidable eye movements may be a cause of glaucoma in people with normal intraocular pressure (normal-tension glaucoma), according to new research supported by the National Eye Institute. The findings suggest that over time eye movement strains the optic nerve, the bundle of nerve fibers between the eye and brain. The research may also explain why tension-lowering eye drops can improve normal-tension glaucoma. Glaucoma is the second leading cause of blindness worldwide and January is Glaucoma Awareness Month.

Newswise: Scientists Find Key to Regenerating Blood Vessels
20-Nov-2017 2:00 PM EST
Scientists Find Key to Regenerating Blood Vessels
Sanford Burnham Prebys

Florida researchers have identified a signaling pathway that is essential for angiogenesis, the growth of new blood vessels from pre-existing vessels. The findings, published in Nature Communications, may improve current strategies to improve blood flow in ischemic tissue, such as that found in atherosclerosis and peripheral vascular disease associated with diabetes.

Newswise: Uncomfortable Sight from an Ancient Reflex of the Eye
Released: 31-Oct-2017 12:00 PM EDT
Uncomfortable Sight from an Ancient Reflex of the Eye
Perelman School of Medicine at the University of Pennsylvania

The eyes are for seeing, but they have other important biological functions, including automatic visual reflexes that go on without awareness. The reflexive system of the human eye also produces a conscious, visual experience, according to a new study from researchers in the Perelman School of Medicine and School of Arts and Sciences at the University of Pennsylvania.

Newswise:Video Embedded university-of-utah-health-identifies-protein-that-plays-key-role-in-diabetic-blindness
VIDEO
18-Oct-2017 2:50 PM EDT
Researchers Identify Protein That Plays Key Role in Diabetic Blindness
University of Utah Health

Researchers at University of Utah Health have identified a protein (ARF6) that when inhibited reduces diabetic retinopathy, a condition that results when blood vessels at the back of the eye leak fluid into the eye, impairing vision.

Newswise: ‘Y’ a Protein Unicorn Might Matter in Blindness
Released: 19-Oct-2017 3:05 PM EDT
‘Y’ a Protein Unicorn Might Matter in Blindness
Georgia Institute of Technology

A protein shaped like a "Y" makes scientists do a double-take and may change the way they think about a protein sometimes implicated in glaucoma. The Y is a centerpiece in myocilin, binding four other components nicknamed propellers together like balloons on strings.

Newswise: Myopia: A Close Look at Efforts to Turn Back a Growing Problem
Released: 5-Oct-2017 2:00 PM EDT
Myopia: A Close Look at Efforts to Turn Back a Growing Problem
NIH, National Eye Institute (NEI)

Several studies indicate that the prevalence of myopia is increasing in the U.S. and worldwide, and researchers project that the trend will continue in the coming decades. Otherwise known as nearsightedness, myopia occurs when the eye grows too long from front to back. Instead of focusing images on the retina—the light-sensitive tissue in the back of the eye—images are focused at a point in front of the retina. As a result, people with myopia have good near vision but poor distance vision.

Released: 1-Aug-2017 10:05 AM EDT
Missing Signals Lead to Diabetic Nerve Injury
Case Western Reserve University

Cytokines might be the key to repairing diabetic nerve damage. Diabetes devastates nerve cells, which can lead to poor circulation, muscle weakness, blindness, and other side effects. The study showed diabetic mice can’t repair nerve cells after damage due to low levels of specific cytokines.

Newswise: Researchers Unlock Regenerative Potential of Cells in the Mouse Retina
25-Jul-2017 4:00 PM EDT
Researchers Unlock Regenerative Potential of Cells in the Mouse Retina
NIH, National Eye Institute (NEI)

Cells within an injured mouse eye can be coaxed into regenerating neurons and those new neurons appear to integrate themselves into the eye’s circuitry, new research shows. The findings potentially open the door to new treatments for eye trauma and retinal disease. The study appears in the July 26 issue of Nature, and was funded in part by the National Eye Institute (NEI), part of the National Institutes of Health.

Newswise: Wayne State University Receives $1.9 Million NIH Grant to Study Bacterial Endophthalmitis
Released: 18-Jul-2017 12:05 PM EDT
Wayne State University Receives $1.9 Million NIH Grant to Study Bacterial Endophthalmitis
Wayne State University Division of Research

A Wayne State University researcher recently received a $1.9 million grant from the National Eye Institute of the National Institutes of Health for the project, “Role of AMP-Activated Protein Kinase in Bacterial Endophthalmitis.” Endophthalmitis is a severe inflammation of the interior of the eye caused by contaminating microorganisms that enter the eye following trauma or surgery, or that spread through the bloodstream from a distant infection site. Despite appropriate therapeutic intervention, bacterial endophthalmitis often results in vision loss and sometimes requires surgical removal of the eye.

Newswise: Eye Microbiome Trains Immune Cells to Fend Off Pathogens in Mice
6-Jul-2017 12:00 PM EDT
Eye Microbiome Trains Immune Cells to Fend Off Pathogens in Mice
NIH, National Eye Institute (NEI)

Bugs in your eyes may be a good thing. Resident microbes living on the eye are essential for immune responses that protect the eye from infection, new research shows. The study, which appears in the journal Immunity on July 11, demonstrates the existence of a resident ocular microbiome that trains the developing immune system to fend off pathogens. The research was conducted at the National Eye Institute (NEI), part of the National Institutes of Health.

Newswise: Wayne State Receives $1.9 M NIH Grant to Develop Novel Therapy for Corneal Bacterial Infection
Released: 15-Jun-2017 3:05 PM EDT
Wayne State Receives $1.9 M NIH Grant to Develop Novel Therapy for Corneal Bacterial Infection
Wayne State University Division of Research

Wayne State University recently received a five-year, $1.925 million grant from the National Eye Institute of the National Institutes of Health to test the role of microRNAs (miRNAs) — a newly recognized level of gene expression regulation — in bacterial keratitis – an infection of the cornea caused by bacteria — as well as to identify new therapeutic targets and alternative treatment strategies.

Newswise: NIH-Funded Clinical Trial Shows Avastin Is as Effective as Eylea for Treatment of Central Retinal Vein Occlusion
8-May-2017 11:15 AM EDT
NIH-Funded Clinical Trial Shows Avastin Is as Effective as Eylea for Treatment of Central Retinal Vein Occlusion
NIH, National Eye Institute (NEI)

Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical trial funded by the National Eye Institute (NEI), part of the National Institutes of Health. After six monthly injections, treatment with either drug improved visual acuity on average from 20/100 to 20/40.

Released: 8-May-2017 11:30 AM EDT
NIH-Funded Clinical Trial Shows Systemic Therapy Outperforms Intraocular Implant for Uveitis
NIH, National Eye Institute (NEI)

Systemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better – and had fewer adverse outcomes – than a long-lasting corticosteroid intraocular implant, according to a clinical trial funded by the National Eye Institute (NEI). After seven years, visual acuity on average remained stable among participants on systemic therapy but declined by an average of six letters (about one line on an eye chart) among participants who had the implant. NEI is part of the National Institutes of Health.

Newswise: Protein That Regulates Brain Cell Connections Could Be New Target for Treating Alzheimer's Disease
23-Mar-2017 11:00 AM EDT
Protein That Regulates Brain Cell Connections Could Be New Target for Treating Alzheimer's Disease
Johns Hopkins Medicine

In experiments with a protein called Ephexin5 that appears to be elevated in the brain cells of Alzheimer's disease patients and mouse models of the disease, Johns Hopkins researchers say removing it prevents animals from developing Alzheimer's characteristic memory losses. In a report on the studies, published online March 27 in The Journal of Clinical Investigation, the researchers say the findings could eventually advance development of drugs that target Ephexin5 to prevent or treat symptoms of the disorder.

Newswise: Myopia Cell Discovered in Retina
Released: 9-Feb-2017 1:05 PM EST
Myopia Cell Discovered in Retina
Northwestern University

Northwestern Medicine scientists have discovered a cell in the retina that may cause myopia when it dysfunctions. The dysfunction may be linked to the amount of time a child spends indoors and away from natural light.

Newswise: Here's Why You Don't Feel Jet-Lagged When You Run a Fever
21-Dec-2016 8:00 AM EST
Here's Why You Don't Feel Jet-Lagged When You Run a Fever
Johns Hopkins Medicine

A clump of just a few thousand brain cells, no bigger than a mustard seed, controls the daily ebb and flow of most bodily processes in mammals -- sleep/wake cycles, most notably. Now, Johns Hopkins scientists report direct evidence in mice for how those cell clusters control sleep and relay light cues about night and day throughout the body.

Newswise: Dual Strategy Teaches Mouse Immune Cells to Overcome Cancer’s Evasive Techniques
Released: 21-Dec-2016 9:00 AM EST
Dual Strategy Teaches Mouse Immune Cells to Overcome Cancer’s Evasive Techniques
Johns Hopkins Medicine

By combining two treatment strategies, both aimed at boosting the immune system’s killer T cells, Johns Hopkins researchers report they lengthened the lives of mice with skin cancer more than by using either strategy on its own. And, they say, because the combination technique is easily tailored to different types of cancer, their findings — if confirmed in humans — have the potential to enhance treatment options for a wide variety of cancer patients.

Newswise: Researchers Turn Back the Clock on Human Embryonic Stem Cells
Released: 14-Dec-2016 12:05 PM EST
Researchers Turn Back the Clock on Human Embryonic Stem Cells
Johns Hopkins Medicine

Johns Hopkins scientists report success in using a cocktail of cell-signaling chemicals to further wind back the biological clock of human embryonic stem cells (ESCs), giving the cells the same flexibility researchers have prized in mice ESCs.

Newswise:Video Embedded u-s-india-joint-effort-targets-genes-and-traits-to-improve-glaucoma-screening-prevention-and-treatment
VIDEO
Released: 29-Sep-2016 2:30 PM EDT
U.S.-India Joint Effort Targets Genes and Traits to Improve Glaucoma Screening, Prevention, and Treatment
NIH, National Eye Institute (NEI)

Researchers from the U.S. and India have begun a new collaborative project to identify genetic risk factors and traits related to glaucoma, a leading cause of blindness worldwide. Funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), and India’s Department of Biotechnology (DBT), the researchers’ goal is to help develop effective screening, prevention, and treatment strategies for glaucoma. Grants from the two agencies stem from a bilateral initiative, the U.S.-India Collaborative Vision Research Program, designed to advance knowledge in the biological mechanisms of ocular disease.

Newswise: Case Western Reserve University Researchers Identify New Drug Cocktail to Protect Mouse Retinas, Potentially Avoiding Blindness
Released: 29-Aug-2016 8:00 AM EDT
Case Western Reserve University Researchers Identify New Drug Cocktail to Protect Mouse Retinas, Potentially Avoiding Blindness
Case Western Reserve University

A gentle combination of FDA-approved drugs could protect critical cells in the eye, called photoreceptor cells, against damage caused by bright light.

Newswise: Use It or Lose It: Visual Activity Regenerates Neural Connections Between Eye and Brain
7-Jul-2016 11:00 AM EDT
Use It or Lose It: Visual Activity Regenerates Neural Connections Between Eye and Brain
NIH, National Eye Institute (NEI)

A study in mice funded by the National Institutes of Health (NIH) shows for the first time that high-contrast visual stimulation can help damaged retinal neurons regrow optic nerve fibers, otherwise known as retinal ganglion cell axons. In combination with chemically induced neural stimulation, axons grew further than in strategies tried previously. Treated mice partially regained visual function. The study also demonstrates that adult regenerated central nervous system (CNS) axons are capable of navigating to correct targets in the brain. The research was funded through the National Eye Institute (NEI), a part of NIH.

Newswise: New Technology Helps ID Aggressive Early Breast Cancer
Released: 30-Jun-2016 2:05 PM EDT
New Technology Helps ID Aggressive Early Breast Cancer
Michigan Medicine - University of Michigan

Researchers at the University of Michigan developed a new technology that can identify aggressive forms of ductal carcinoma in situ, or stage 0 breast cancer, from non-aggressive varieties.

Newswise: A Little Spark for Sharper Sight
29-Jun-2016 3:00 PM EDT
A Little Spark for Sharper Sight
Vanderbilt University

Stimulating the brain with a mild electrical current can temporarily sharpen vision without glasses or contacts, Vanderbilt University researchers have found.

Newswise: Study Sets Standards for Evaluating Pluripotent Stem Cell Quality
6-Jun-2016 10:00 AM EDT
Study Sets Standards for Evaluating Pluripotent Stem Cell Quality
Cincinnati Children's Hospital Medical Center

As the promise of using regenerative stem cell therapies draws closer, a consortium of biomedical scientists reports about 30 percent of induced pluripotent stem cells they analyzed from 10 research institutions were genetically unstable and not safe for clinical use. In a study published June 9 by the journal Stem Cell Reports, the multi-institutional research team reports on the comprehensive characterization of a large set of induced pluripotent stem cells (iPSCs).

Newswise:Video Embedded visual-impairment-blindness-cases-in-u-s-expected-to-double-by-2050
VIDEO
18-May-2016 1:00 PM EDT
Visual Impairment, Blindness Cases in U.S. Expected to Double by 2050
NIH, National Eye Institute (NEI)

The number of people with visual impairment or blindness in the United States is expected to double to more than 8 million by 2050, according to projections based on the most recent census data and from studies funded by the National Eye Institute, part of the National Institutes of Health. Another 16.4 million Americans are expected to have difficulty seeing due to correctable refractive errors that can be fixed with glasses, contacts or surgery.


Showing results

150 of 65

close
2.4461